Title: Renal dysfunction in COPD patients - an Observational Study

Authors: Dr Sharanya MD, Dr S L Ravi M.D

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i8.203

Abstract

INTRODUCTION

COPD is the third leading cause of death worldwide killing more than 10 million persons in the United States. It is estimated that COPD will rise from the sixth to the third most common cause of death worldwide by 2020.COPD is estimated to cause half a million deaths annually in India. The prevalence of COPD in India is estimated to be 3.49% based on nationwide prevalence study conducted by ICMR.

References

  1. COPD: The neglected epidemic; Textbook of Pulmonary and Critical Care Med Vol 2, Ed: Jindal SK, Jaypee Publications, 2011;971974.
  2. The Global Burden of Disease, WHO 2008 Oct, who.int/healthinfo/global_burden_disease/projections/en/index.html.Jindal SK et al. Indian multi-centric study on epidemiology of asthma and chronic bronchitis in adults (INSEARCH) Study, ICMR Report, 2010.
  3. Salvi S, Barnes PJ: Is exposure to biomass smoke the biggest risk factorfor COPD globally?; Chest 2010;138:3-6.
  4. The 2006 GOLD COPD guidelines, www.goldcopd.com;Celli BR, MacNee W: ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS positionpaper;EurRespir J 23:934; 2004
  5. American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency; Am J RespirCrit Care Med 168:818–900, 2003.
  6. Celli BR, Cote CG, Marin JM, et al: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructivepulmonary disease; N Engl J Med 350:1005–1012; 2004.
  7. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global initiative for Chronic Obstructive Lung Disease(GOLD)2016 www.goldcopd.org(March 17,2016)

Corresponding Author

Dr Sharanya MD

VIMS, Ballari